Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Stupp

Showing results (31-40 of 314) with videos related to

Pageof 32
Sort By:
Annals of Medicine|December 3, 2003
Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realityCurzio Rüegg, Jelena Zaric, Roger Stupp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Informed consent: true information or institutional review board-approved disinformation?Martine Rossel, Michel Burnier, Roger Stupp
Expert Review of Anticancer Therapy|November 18, 2010
Neuro-oncology, a decade of temozolomide and beyondRoger Stupp, Monika Hegi, Michael Weller
The Lancet. Oncology|December 3, 2014
Does cilengitide deserve another chance?-Authors' replyRoger Stupp, Martin Picard, Michael Weller
Disease Markers|February 28, 2007
MGMT methylation status: the advent of stratified therapy in glioblastoma?Peter Hau, Roger Stupp, Monika E Hegi
Clinical Neurology and Neurosurgery|November 4, 2008
Pregabalin in patients with primary brain tumors and seizures: a preliminary observationJan Novy, Roger Stupp, Andrea O Rossetti
JAMA|June 9, 2016
Treatment for Patients With Newly Diagnosed Glioblastoma--ReplyRoger Stupp, Steven A Toms, Santosh Kesari
Cancers|July 25, 2019
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?Begoña Alday-Parejo, Roger Stupp, Curzio Rüegg
Chinese Journal of Cancer|January 4, 2014
Standards of care and novel approaches in the management of glioblastoma multiformeAndreas F Hottinger, Roger Stupp, Krisztian Homicsko
Neuro-Oncology|September 25, 2016
Tumor treating fields: a novel treatment modality and its use in brain tumorsAndreas F Hottinger, Patricia Pacheco, Roger Stupp
Pageof 32

Showing results (31-40 of 314) with videos related to

Sort By:
Pageof 32
Annals of Medicine|December 3, 2003
Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and realityCurzio Rüegg, Jelena Zaric, Roger Stupp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Informed consent: true information or institutional review board-approved disinformation?Martine Rossel, Michel Burnier, Roger Stupp
Expert Review of Anticancer Therapy|November 18, 2010
Neuro-oncology, a decade of temozolomide and beyondRoger Stupp, Monika Hegi, Michael Weller
The Lancet. Oncology|December 3, 2014
Does cilengitide deserve another chance?-Authors' replyRoger Stupp, Martin Picard, Michael Weller
Disease Markers|February 28, 2007
MGMT methylation status: the advent of stratified therapy in glioblastoma?Peter Hau, Roger Stupp, Monika E Hegi
Clinical Neurology and Neurosurgery|November 4, 2008
Pregabalin in patients with primary brain tumors and seizures: a preliminary observationJan Novy, Roger Stupp, Andrea O Rossetti
JAMA|June 9, 2016
Treatment for Patients With Newly Diagnosed Glioblastoma--ReplyRoger Stupp, Steven A Toms, Santosh Kesari
Cancers|July 25, 2019
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?Begoña Alday-Parejo, Roger Stupp, Curzio Rüegg
Chinese Journal of Cancer|January 4, 2014
Standards of care and novel approaches in the management of glioblastoma multiformeAndreas F Hottinger, Roger Stupp, Krisztian Homicsko
Neuro-Oncology|September 25, 2016
Tumor treating fields: a novel treatment modality and its use in brain tumorsAndreas F Hottinger, Patricia Pacheco, Roger Stupp
Pageof 32